Exclusives

3M announced its Board of Directors has approved the planned spin-off of its Health Care business, which will be known as Solventum Corporation. The company is anticipated to spin off from 3M on April 1, 2024, and has applied to list on the...

Healthy.io and John Hopkins collaborate to utilize new patient-facing technology to improve wound care management. The pilot program expands access to Healthy.io's smartphone-based Minuteful for Wounds tool for remote monitoring of patients...

Researchers at Texas Tech Univ Health Sciences were awarded a $434,938 NIH grant to investigate biofilm dispersal agents using specific enzymes as tools to understand bacteria when they're dispersed from a biofilm and their role in wound...

Convatec aims to have the first wound care product regulatory approval from the acquired anti-infective nitric oxide technology platform in 2025. SmartTRAK notes that the newly formed UK legal entity for this acquisition is Starlight Science...

PolarityTE announced the screening of the first subject in the Phase III pivotal study evaluating the investigational new drug SkinTE for the treatment of Wagner grade 1 DFUs. The study (COVER DFUS II) will enroll up to 120 subjects at 20...

Recce announced the expansion of its ongoing Phase I/II trial evaluating the safety and efficacy of its RECCE 327 in patients with diabetic foot infections based on interim data analysis and the study achieving its primary endpoints....

A 100-patient interventional clinical study will evaluate the efficacy of ProgenaMatrix in the management of DFUs with the primary outcome of time to wound closure at 12 weeks in patients not responding to traditional moist therapy. Not yet...

VCEL noted CMS granted NexoBrid a permanent J code and transitional pass-through payment status as of Jan 1st and provides a reimbursement pathway for the outpatient treatment of NexoBrid patients in its target burn centers. VCEL Q423...